FRAX Calculated without BMD Resulting in a Higher Fracture Risk Than That Calculated with BMD in Women with Early Breast Cancer.

Journal: Journal of osteoporosis
Published Date: Oct 4, 2018

Abstract

BACKGROUND AND PURPOSE: The aim of this study was to investigate the importance of including the measurement of bone mineral density (BMD) in reliable fracture risk assessment for women diagnosed with early nonmetastatic breast cancer (EBC) before AI treatment if zoledronic acid is not an option.

Authors

  • Rizky Suganda Prawiradilaga
    Department of Nutrition, Exercise, and Sports, University of Copenhagen, Nørre Allé 51, 2200 Copenhagen N, Denmark.
  • Victoria Gunmalm
    Department of Endocrinology, Rigshospitalet, Copenhagen, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark.
  • Trine Lund-Jacobsen
    Department of Endocrinology, Rigshospitalet, Copenhagen, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark.
  • Eva Wulff Helge
    Department of Nutrition, Exercise, and Sports, University of Copenhagen, Nørre Allé 51, 2200 Copenhagen N, Denmark.
  • Charlotte Brøns
    Department of Endocrinology, Rigshospitalet, Copenhagen, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark.
  • Michael Andersson
    Department of Oncology, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark.
  • Peter Schwarz
    Department of Endocrinology, Rigshospitalet, Copenhagen, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals